Origin
AI and Data for Cancer Therapeutics
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Creating the largest patient-derived cancer single-cell dataset for licensing to pharmaceutical and AI companies. These datasets are unique as they screen the effects of various drugs and genetic medicines under the control of our DNA switches. Origin is a Y Combinator company (Winter 2026). YC-listed status: Active.
- Website
- origin.bio
- Location
- San Francisco, CA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Origin — Cancer single-cell dataset platform that maps tumor biology from patient tissue to train models predicting drug response and identifying biomarkers before… · Other · Enterprise
Links
- Y Combinator profileycombinator